1TMB image
Deposition Date 1993-05-27
Release Date 1994-01-31
Last Version Date 2023-11-15
Entry Detail
PDB ID:
1TMB
Title:
MOLECULAR BASIS FOR THE INHIBITION OF HUMAN ALPHA-THROMBIN BY THE MACROCYCLIC PEPTIDE CYCLOTHEONAMIDE A
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Theonella sp. (Taxon ID: 73791)
Method Details:
Experimental Method:
Resolution:
2.30 Å
R-Value Observed:
0.13
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:ALPHA-THROMBIN (LARGE SUBUNIT)
Gene (Uniprot):F2
Chain IDs:B (auth: H)
Chain Length:259
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:ALPHA-THROMBIN (SMALL SUBUNIT)
Gene (Uniprot):F2
Chain IDs:A (auth: L)
Chain Length:36
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:cyclotheonamide A
Chain IDs:D (auth: T)
Chain Length:5
Number of Molecules:1
Biological Source:Theonella sp.
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
0FL D ALA 3-AMINO-N-FORMYL-L-ALANINE
TYS C TYR O-SULFO-L-TYROSINE
Peptide-like Molecules
PRD_000428
Primary Citation
Molecular basis for the inhibition of human alpha-thrombin by the macrocyclic peptide cyclotheonamide A.
Proc.Natl.Acad.Sci.USA 90 8048 8052 (1993)
PMID: 8367461 DOI: 10.1073/pnas.90.17.8048

Abstact

The macrocyclic peptide cyclotheonamide A (CtA), isolated from the marine sponge Theonella sp., represents an unusual class of serine protease inhibitor. A complex of this inhibitor with human alpha-thrombin, a protease central to the bioregulation of thrombosis and hemostasis, was studied by x-ray crystallography. This work (2.3-A resolution) confirms the structure of CtA and reveals intimate details about its molecular recognition within the enzyme active site. Interactions due to the "Pro-Arg motif" (Arg occupancy of the S1 specificity pocket; formation of a hydrogen-bonded two-strand antiparallel beta-sheet with Ser214-Gly216) and the alpha-keto amide group of CtA are primarily responsible for binding to thrombin, with the alpha-keto amide serving as a transition-state analogue. A special interaction with the "insertion loop" of thrombin (Tyr60A-Thr60I) is manifested through engagement of the hydroxyphenyl group of CtA with Trp60D as part of an "aromatic stacking chain." Biochemical inhibition data (Ki values at 37 degrees C) were obtained for CtA with thrombin and a diverse collection of serine proteases. Thus, CtA is just a moderate inhibitor of human alpha-thrombin (Ki = 0.18 microM) but a potent inhibitor of trypsin (Ki = 0.023 microM) and streptokinase (Ki = 0.035 microM). The relative lack of potency of CtA as a thrombin inhibitor is discussed with respect to certain structural features of the enzyme complex. We also report the total synthesis of CtA, by a convergent [2 + 3] fragment-condensation approach, to serve the preparation of cyclotheonamide analogues for structure-function studies.

Legend

Protein

Chemical

Disease

Primary Citation of related structures